Wembrace Biopharma Private Limited, a active private limited company, was established on 22 August 2022 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234DL2022PTC403415. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.10 M.
Employing 49 professional, Its leadership includes Sugandha Daga (Director), Dinesh Mohan Daga (Director). Past directors included Abhay Daga. It holds ₹8.00 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-6/9, Commercial Complex, Safdarjung Enclave, New Delhi, Delhi, 110029.
U24234DL2022PTC403415
403415
22 August 2022
₹1.00 Cr
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Wembrace Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sugandha Daga | Director | 22 Aug 2022 | Current |
| Dinesh Mohan Daga | Director | 22 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Wembrace Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Wembrace Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2023 | Others | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Wembrace Biopharma has a workforce of 49 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wembrace Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wembrace Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Wembrace Biopharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
Wembrace Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Others of Rs. 8.00 Cr registered on 02 May 2023 with Charge ID 100716921 was modified on 29 Apr 2024. was documented.
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100716921 was registered on 02 May 2023. was recorded as a recent event.
The activity Sugandha Daga was appointed as a Director was appointed as a Director on 22 Aug 2022 & has been associated with this company since 3 years 3 months . was completed.
Dinesh Mohan Daga was appointed as a Director was appointed as a Director on 22 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The CIN of Wembrace Biopharma Private Limited is U24234DL2022PTC403415.
Wembrace Biopharma Private Limited is headquartered at B-6/9, Commercial Complex, Safdarjung Enclave, New Delhi, Delhi, 110029.
Wembrace Biopharma Private Limited was incorporated on 22 August 2022.
The current directors of Wembrace Biopharma Private Limited are
The primary industry of Wembrace Biopharma Private Limited is Manufacturing.
Wembrace Biopharma Private Limited is unlisted.
The authorized capital of Wembrace Biopharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX